JP Morgan Chase
QNTM

JP Morgan Chase’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

JP Morgan Chase’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-577
Closed -$4.21K – 7994
2025
Q4 		$4.21K Sell
577
-159
-22% -$1.74K ﹤0.01% 6834
2025
Q3 		$12.1K Sell
736
-161
-18% -$3.18K ﹤0.01% 6594
2025
Q2 		$18.2K Buy
+897
New +$11.1K ﹤0.01% 6195

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

JP Morgan Chase's QNTM Position: Q1 2026 in Review

JP Morgan Chase sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2026, closing a stake of 577 shares — an estimated $4.21K sold.

JP Morgan Chase first reported a position in QNTM in Q2 2025 and held it in 3 quarters. The position peaked at $18.2K in Q2 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • JP Morgan Chase reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 577 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $4.21K.
  • JP Morgan Chase first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2025 and held it in 3 quarters.
  • JP Morgan Chase's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $18.2K in Q2 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.